KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) EPS (Weighted Average and Diluted) (QoQ) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -61.76%
Dec 31, 2025 920.00%
Sep 30, 2025 -80.77%
Jun 30, 2025 -27.78%
Mar 31, 2025 3,700.00%
Dec 31, 2024 -102.27%
Sep 30, 2024 14.29%
Jun 30, 2024 0.00%
Mar 31, 2024 67.39%
Dec 31, 2023 -54.00%
Sep 30, 2023 -12.28%
Jun 30, 2023 776.92%
Mar 31, 2023 -90.58%
Dec 31, 2022 -37.56%
Sep 30, 2022 333.33%
Jun 30, 2022 -79.68%
Mar 31, 2022 11.06%
Dec 31, 2021 26.97%
Sep 30, 2021 323.81%
Jun 30, 2021 -78.89%
Mar 31, 2021 19,800.00%
Dec 31, 2020 -99.22%
Sep 30, 2020 380.43%
Jun 30, 2020 -122.77%
Mar 31, 2020 7.45%
Dec 31, 2019 49.21%
Sep 30, 2019 157.14%
Jun 30, 2019 -70.30%
Mar 31, 2019 234.15%
Dec 31, 2018 -167.96%
Sep 30, 2018 43.65%
Jun 30, 2018 -27.59%
Mar 31, 2018 5,700.00%
Dec 31, 2017 -97.03%
Sep 30, 2017 -15.13%
Jun 30, 2017 12.26%
Mar 31, 2017 24.71%
Dec 31, 2016 -12.37%
Sep 30, 2016 -1.02%
Jun 30, 2016 18.07%
Mar 31, 2016 -9.78%
Dec 31, 2015 24.32%
Sep 30, 2015 -10.84%
Jun 30, 2015 31.75%
Mar 31, 2015 223.53%
Dec 31, 2014 -264.52%
Sep 30, 2014 -54.41%
Jun 30, 2014 11.48%
Mar 31, 2014 -12.86%
Dec 31, 2013 16.67%
Sep 30, 2013 -9.09%
Jun 30, 2013 10.00%
Mar 31, 2013 -38.78%
Dec 31, 2012 -2.97%
Sep 30, 2012 26.25%
Jun 30, 2012 42.86%